Any undesirable experience associated with the use of a medical product, whether or not considered related to the product. Serious adverse events include hospitalization, disability, or life-threatening outcomes.
"Adverse Event" is filed under Clinical & Safety in the PeptideAtlas glossary, alongside 15 other terms in that group.
2 other glossary entries refer to this term in their own definition, which is usually the fastest way to see how it is used in practice.
The FDA's safety information and adverse event reporting program. Healthcare professionals and consumers can report adverse events from peptide medications through MedWatch.
Inflammation of the pancreas causing severe abdominal pain. Monitored as a potential adverse event with GLP-1 receptor agonists. Patients are advised to seek immediate medical attention for severe abdominal pain.
A condition or factor that makes a particular treatment or procedure inadvisable. Absolute contraindications mean the treatment should never be used; relative contraindications mean the benefits may outweigh risks in some cases.
The FDA's most serious warning placed on a drug's prescribing information, indicating significant risks of serious or life-threatening adverse effects. GLP-1 agonists carry a black box warning for thyroid C-cell tumors based on rodent studies.
Terms that reference this one: MedWatch, Pancreatitis.
More Clinical & Safety terms: Contraindication, Black Box Warning, Therapeutic Window, Drug Interaction, Washout Period, Anaphylaxis, Immunogenicity, Anti-Drug Antibodies (ADA), MedWatch, REMS (Risk Evaluation and Mitigation Strategy), Gastroparesis, Pancreatitis, Gallbladder Disease, Injection Site Reaction, Sterile Abscess.